|
So as you know Total USD $15,419,785 for Smart Containers has been raised.
Here are the breakdowns for each token:
USD $15,004,358 for SMARC
USD $415,427 for LOGI
|
|
|
|
Anyone see how the Coinbase wallet has Codex near the top of the listed DApps? Bullish!
Yes, I checked it out today and added a 35mm photo I took to my collection!  These are the options, you can access them in the top right, where there are 3 bars  |
|
|
|
Did you know you can get 20% bonus in the Pre Sale? Register your interest now at https://www.clintex.io/ and sign up in the Token Sale section |
|
|
|
Hello, when is the end of this project ICO?
Also, why there's no update in your twitter handle from August-current date?
Hi there, the dates of the sale are not set yet, you can keep up to date by joining the conversation on telegram: https://t.me/orvium |
|
|
|
I want to ask about the project. How do you tackle industry-sponsored clinical trials, as you know all of them are manipulated to fit the customer?
Mainly, Orvium is looking to be eliminating market inefficiencies and improve the quality and effectiveness of scientific publishing that is in the current outdated model, Orvium is looking to be the leading platform for the research community which will give the benefits back to the community so that everyone involved will benefit more. The team hasn't specifically mentioned this collusion that you are talking about with regards to clinical trials, however, you can see that the team plans on building a lot of governance within the platform, for example, there will be a reputation based voting power which will determine the reputation of individual contributors. So hopefully, the more freedom of contributors will stop this issue you are talking about by other trials results being posted with great reviews, for instance, seems like this would be the future and hopefully the downfall of the current publishing methods in my opinion. You can read more on the full Community driven journals and governance rules from page 23 of the whitepaper: https://orvium.docsend.com/view/nvr6ywj |
|
|
|
ClinTex have already established a partnership with Intellimed to deploy the CTi platform in academic clinical
research settings. Further addition to the customer base is targeted for mid-2019, when on-boarding of pharmaceutical companies conducting clinical trials will begin  |
|
|
|
Tell me more about the project. How do you tackle industry-sponsored clinical trials, as you know they are all manipulated to suit the client?
Mainly, Orvium is looking to be eliminating market inefficiencies and improve the quality and effectiveness of scientific publishing that is in the current outdated model, Orvium is looking to be the leading platform for the research community which will give the benefits back to the community so that everyone involved will benefit more. The team hasn't specifically mentioned this collusion that you are talking about with regards to clinical trials, however, you can see that the team plans on building a lot of governance within the platform, for example, there will be a reputation based voting power which will determine the reputation of individual contributors. So hopefully, the more freedom of contributors will stop this issue you are talking about by other trials results being posted with great reviews, for instance, seems like this would be the future and hopefully the downfall of the current publishing methods in my opinion. You can read more on the full Community driven journals and governance rules from page 23 of the whitepaper: https://orvium.docsend.com/view/nvr6ywj |
|
|
|
Will the token become more scarce? Thus building it's value progressively? it is envisioned that the majority of the customer base will renew their CTi licence as the expiration period approaches, meaning that 100% of their staked tokens will be continuously removed from the supply pool. However, in cases where a client of the ClinTex UK subsidiary allows a licence to expire, 25% of their staked tokens will be destroyed permanently before the rest are returned to the circulating supply. This will be part of the contract the pharmaceutical client signs with ClinTex UK, and the token burn will be verifiable by smart contract.  |
|
|
|
How can you contribute to this project?ClinTex will be accepting ETH (Ethereum), BTC (Bitcoin) and BNB (Binance Coin) Why Binance coin? Whilst ClinTex do not have an official partnership with Binance. However, as supporters of Binance’s contribution to the cryptocurrency space, the team are happy to endorse BNB and the Binance eco-system by accepting BNB in the TGE, along with BTC and ETH Just to confirm all pre-sale participants will receive a 20% bonus. The public TGE will also have a 5% bonus, for the first 24 hours only. Need to know something more? Join the chat here: https://t.me/ClinTexCTi
|
|
|
|
Did you know there will be a referral system up with a 5% bonus! where a TGE participant that refers another TGE participant, the referee will get a bonus of 5% of the CLX that the person they referred purchasesWhile we are on the point of the Token sale, here is a chart to show what that looks like  |
|
|
|
Check out this short explainer video for ClinTex and let us know what you think  "Learn more about ClinTex and our Clinical Trials Intelligence (CTi) Platform that uses advanced analytics to optimise Operational Efficiency, Clinical Data Quality and Medical Review in clinical trials. Our innovative use of blockchain technology makes machine learning and collaboration possible for clinical trials, helping the pharmaceutical industry to exploit the opportunities of Big Data, and its application to faster, more efficient medicines development."https://www.youtube.com/watch?v=uDUMxCh-gBI |
|
|
|
Want to know what the plan for disruption looks like?Check out the team's road map here: 
|
|
|
|
|
Show Posts
